Nike Mag auction raises nearly $7m for Parkinson’s cure research

Global update

Author: Parkinson's Life editorsPublished: 21 October 2016

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Nike Mag lead

Michael J Fox applauds Nike as it raises million for his Foundation by auctioning pairs of the Nike Mag trainers with iconic ‘power laces’


Nike has raised US$6.75 million for the Michael J Fox Foundation (MJFF) after auctioning 88 pairs of the self-lacing ‘Mag’ trainers – as worn by Fox in the classic 1989 film ‘Back to the Future II’.

Trainer aficionados worldwide were invited to take part in an online draw for the chance to win a pair. They made donations of $10 per entry to the Foundation, which promised that all proceeds “will go straight to speeding a cure for Parkinson’s disease”.

Thanks to an anonymous donor, donations in the last 12 hours of the draw were doubled and matched dollar for dollar. The winners of the limited-edition sneakers were announced on October 17. The 89th pair of Nike Mags will be auctioned to the highest bidder at the Foundation’s benefit gala on November 12 in New York City.

A similar event took place in 2011, when Nike held a 10-day eBay auction of 1,500 pairs of Nike Mag sneakers. In total, the company has now raised more than $16 million for the Foundation.

Michael J Fox said: “Thanks to Nike, we’ve raised a boatload of money for research and we’ve had tons of fun while doing it. We’re grateful to everyone who’s engaged in our work and we welcome those who have come to learn more about us through this amazing partnership.”

Nike Mag

Go Back

Share this story

Comments


Related articles


Young woman sleeping in bed beside the window

Carers' Corner

How my husband’s Parkinson’s has ruined our sex life

A candid account of sex life and Parkinson’s

READ MORE
Debate

Perspectives

Debate: are people with Parkinson’s “sick”? (Part One)

The first in a two-part series

READ MORE
OraFuse-lead

Advances

83-year-old invents Parkinson’s ‘retainer’ to deliver oral levodopa via the mouth

New device delivers oral levodopa at continuous, controlled rate

READ MORE